Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:12:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page revision history shows removal of v3.4.1 and addition of v3.4.2; there are no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:57:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision badge updated from v3.4.0 to v3.4.1 on the page. No substantive content or functionality changes were detected.
    Difference
    0.0%
    Check dated 2026-02-05T17:20:33.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study content or user-facing features were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:04:02.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    An administrative revision tag 'Revision: v3.3.3' was added and the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T18:55:11.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by the person entering study information. The revision tag is updated to v3.3.2, replacing the old v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-26T13:47:46.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.